Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan vs Losartan in Hypertension with Heart Failure
NCT01766505Phase 4Terminated
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jun 2012
- Primary completion
- Mar 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan cilexetil in hypertension (HTN), heart failure (HF), sponsored by Chong Kun Dang Holdings. Started Jun 2012; status: terminated.
02
Drugs
candesartan cilexetil
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT01766505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766505.